Invenomic Capital Management LP Grows Stock Holdings in John B. Sanfilippo & Son, Inc. $JBSS

Invenomic Capital Management LP grew its holdings in John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) by 161.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,474 shares of the company’s stock after purchasing an additional 47,864 shares during the quarter. Invenomic Capital Management LP’s holdings in John B. Sanfilippo & Son were worth $5,470,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. Dimensional Fund Advisors LP lifted its stake in John B. Sanfilippo & Son by 1.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 300,746 shares of the company’s stock worth $21,233,000 after purchasing an additional 3,007 shares in the last quarter. Deutsche Bank AG lifted its stake in John B. Sanfilippo & Son by 22.8% in the 4th quarter. Deutsche Bank AG now owns 256,526 shares of the company’s stock worth $18,111,000 after purchasing an additional 47,559 shares in the last quarter. Royce & Associates LP lifted its stake in John B. Sanfilippo & Son by 2.5% in the 4th quarter. Royce & Associates LP now owns 249,068 shares of the company’s stock worth $17,584,000 after purchasing an additional 6,170 shares in the last quarter. Gamco Investors INC. ET AL lifted its stake in John B. Sanfilippo & Son by 19.1% in the 4th quarter. Gamco Investors INC. ET AL now owns 204,325 shares of the company’s stock worth $14,425,000 after purchasing an additional 32,800 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its stake in John B. Sanfilippo & Son by 2.6% in the 3rd quarter. Ameriprise Financial Inc. now owns 152,762 shares of the company’s stock worth $9,820,000 after purchasing an additional 3,866 shares in the last quarter. 70.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on JBSS. Weiss Ratings raised shares of John B. Sanfilippo & Son from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, June 11th. Wall Street Zen lowered shares of John B. Sanfilippo & Son from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 23rd. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, John B. Sanfilippo & Son has a consensus rating of “Hold” and a consensus target price of $109.00.

John B. Sanfilippo & Son Stock Down 0.9%

JBSS stock opened at $77.65 on Thursday. The firm has a market cap of $907.73 million, a PE ratio of 13.62 and a beta of 0.34. The company has a debt-to-equity ratio of 0.10, a quick ratio of 0.65 and a current ratio of 2.30. The firm’s 50 day moving average price is $78.09 and its 200-day moving average price is $76.81. John B. Sanfilippo & Son, Inc. has a one year low of $59.07 and a one year high of $85.15.

John B. Sanfilippo & Son (NASDAQ:JBSS) last released its quarterly earnings results on Wednesday, April 29th. The company reported $1.43 EPS for the quarter, beating the consensus estimate of $1.16 by $0.27. The firm had revenue of $281.78 million for the quarter, compared to analyst estimates of $260.83 million. John B. Sanfilippo & Son had a net margin of 5.76% and a return on equity of 18.11%. On average, equities research analysts anticipate that John B. Sanfilippo & Son, Inc. will post 5.85 EPS for the current year.

John B. Sanfilippo & Son Announces Dividend

The company also recently declared a special dividend, which was paid on Thursday, May 21st. Stockholders of record on Monday, April 27th were given a dividend of $1.50 per share. The ex-dividend date of this dividend was Monday, April 27th. John B. Sanfilippo & Son’s payout ratio is presently 15.79%.

John B. Sanfilippo & Son Company Profile

John B. Sanfilippo & Son, Inc is a family‐held processor and marketer of tree nuts and snack nut products. Headquartered in Elgin, Illinois, the company operates manufacturing facilities, processing plants and sales offices across the United States and abroad. It supplies a broad range of channels, including retail, foodservice, industrial and private‐label customers.

The company’s product portfolio spans in‐shell and shelled pecans, walnuts, almonds, cashews, pistachios and peanuts, as well as mixed‐nut blends, chocolate‐covered treats, granolas and specialty snack items.